ID   GM00730
AC   CVCL_L944
SY   GM0730; GM-730; GM 730; GM730; GM00730A; GM0730A; GM00238; GM0238
DR   CLO; CLO_0028809
DR   Coriell; GM00238
DR   Coriell; GM00730
DR   GEO; GSM1316970
DR   GEO; GSM1317006
DR   Wikidata; Q54836422
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.1007/978-1-4757-1117-2_12;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2897722;
RX   PubMed=2903889;
RX   PubMed=2973075;
RX   PubMed=3180052;
RX   PubMed=6220707;
RX   PubMed=6307543;
RX   PubMed=6442144;
RX   PubMed=6600729;
RX   PubMed=6843573;
RX   PubMed=7067035;
RX   PubMed=11219864;
RX   PubMed=18079351;
RX   PubMed=19896956;
CC   Population: Caucasian.
CC   Omics: miRNA expression profiling.
CC   Omics: Transcriptome analysis by microarray.
CC   Discontinued: Coriell; GM00238; true.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 20
//
RX   CelloPub=CLPUB00387;
RA   Coriell L.L., Greene A.E., Mulivor R.A.;
RT   "The human genetic mutant cell repository: list of genetic variants,
RT   chromosomal aberrations and normal cell cultures submitted to the
RT   repository. 7th edition. October 1980.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 80-2011; pp.1-254; National Institutes of Health; Bethesda (1980).
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   CelloPub=CLPUB00720;
RA   Greene A.E., Mulivor R.A.;
RT   "1986/1987 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 13th edition. October 1986.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 87-2011; pp.1-549; National Institutes of Health; Bethesda (1986).
//
RX   DOI=10.1007/978-1-4757-1117-2_12;
RA   Arlett C.F., Harcourt S.A.;
RT   "The mutagen sensitivity response of cells from individuals
RT   heterozygous for DNA repair deficiency genes.";
RL   (In) The use of human cells for the evaluation of risk from physical and chemical agents; Castellani A. (eds.); pp.155-167; Springer; Boston (1983).
//
RX   DOI=10.5962/bhl.title.4090;
RA   Coriell L.L., Greene A.E.;
RT   "The human genetic mutant cell repository: list of genetic variants,
RT   chromosomal aberrations and normal cell cultures submitted to the
RT   repository. 4th edition. October 1977.";
RL   (In) Institute for Medical Research (Camden, N.J.); pp.1-171; National Institutes of Health; Bethesda (1977).
//
RX   PubMed=2897722; DOI=10.1002/tcm.1770080104;
RA   Nagasawa H., Burke M.J., Little F.F., McCone E.F., Chan G.L.,
RA   Little J.B.;
RT   "Multiple abnormalities in the ultraviolet light response of cultured
RT   fibroblasts derived from patients with the basal cell nevus syndrome.";
RL   Teratog. Carcinog. Mutagen. 8:25-33(1988).
//
RX   PubMed=2903889; DOI=10.1080/09553008814552321;
RA   Arlett C.F., Green M.H.L., Priestley A., Harcourt S.A., Mayne L.V.;
RT   "Comparative human cellular radiosensitivity: I. The effect of SV40
RT   transformation and immortalisation on the gamma-irradiation survival
RT   of skin derived fibroblasts from normal individuals and from
RT   ataxia-telangiectasia patients and heterozygotes.";
RL   Int. J. Radiat. Biol. 54:911-928(1988).
//
RX   PubMed=2973075; DOI=10.2307/3577479;
RA   Fertil B., Deschavanne P.J., Debieu D., Malaise E.-P.;
RT   "Correlation between PLD repair capacity and the survival curve of
RT   human fibroblasts in exponential growth phase: analysis in terms of
RT   several parameters.";
RL   Radiat. Res. 116:74-88(1988).
//
RX   PubMed=3180052;
RA   Lehmann A.R., Willis A.E., Broughton B.C., James M.R.,
RA   Steingrimsdottir H., Harcourt S.A., Arlett C.F., Lindahl T.R.;
RT   "Relation between the human fibroblast strain 46BR and cell lines
RT   representative of Bloom's syndrome.";
RL   Cancer Res. 48:6343-6347(1988).
//
RX   PubMed=6220707; DOI=10.1016/0006-291x(83)90361-3;
RA   Chua C.C., Geiman D.E., Ladda R.L.;
RT   "Detection of an Mr 200,000 glycoprotein in the culture medium of skin
RT   fibroblasts from patients with Huntington disease.";
RL   Biochem. Biophys. Res. Commun. 111:690-699(1983).
//
RX   PubMed=6307543; DOI=10.1093/carcin/4.8.1075;
RA   Teo I.A., Lehmann A.R., Muller R., Rajewsky M.F.;
RT   "Similar rate of O6-ethylguanine elimination from DNA in normal human
RT   fibroblast and xeroderma pigmentosum cell strains not transformed by
RT   SV40.";
RL   Carcinogenesis 4:1075-1077(1983).
//
RX   PubMed=6442144; DOI=10.1007/978-1-4684-4892-4_20;
RA   Nagasawa H., Little F.F., Burke M.J., McCone E.F., Targovnik H.S.,
RA   Chan G.L., Little J.B.;
RT   "Study of basal cell nevus syndrome fibroblasts after treatment with
RT   DNA-damaging agents.";
RL   Basic Life Sci. 29:775-785(1984).
//
RX   PubMed=6600729; DOI=10.1080/09553008314550171;
RA   Arlett C.F., Priestley A.;
RT   "Defective recovery from potentially lethal damage in some human
RT   fibroblast cell strains.";
RL   Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 43:157-167(1983).
//
RX   PubMed=6843573; DOI=10.1016/0027-5107(83)90054-4;
RA   Nagasawa H., Little J.B.;
RT   "Comparison of kinetics of X-ray-induced cell killing in normal,
RT   ataxia telangiectasia and hereditary retinoblastoma fibroblasts.";
RL   Mutat. Res. 109:297-308(1983).
//
RX   PubMed=7067035; DOI=10.1093/carcin/3.1.33;
RA   Teo I.A., Arlett C.F.;
RT   "The response of a variety of human fibroblast cell strains to the
RT   lethal effects of alkylating agents.";
RL   Carcinogenesis 3:33-37(1982).
//
RX   PubMed=11219864; DOI=10.1093/carcin/1.9.745;
RA   Arlett C.F., Harcourt S.A., Lehmann A.R., Stevens S.,
RA   Ferguson-Smith M.A., Morley W.N.;
RT   "Studies on a new case of xeroderma pigmentosum (XP3BR) from
RT   complementation group G with cellular sensitivity to ionizing
RT   radiation.";
RL   Carcinogenesis 1:745-751(1980).
//
RX   PubMed=18079351; DOI=10.1259/bjr/27072321;
RA   Arlett C.F., Green M.H.L., Rogers P.B., Lehmann A.R., Plowman P.N.;
RT   "Minimal ionizing radiation sensitivity in a large cohort of xeroderma
RT   pigmentosum fibroblasts.";
RL   Br. J. Radiol. 81:51-58(2008).
//
RX   PubMed=19896956; DOI=10.1016/j.mrfmmm.2009.10.013;
RA   Wilson P.F., Nham P.B., Urbin S.S., Hinz J.M., Jones I.M.,
RA   Thompson L.H.;
RT   "Inter-individual variation in DNA double-strand break repair in human
RT   fibroblasts before and after exposure to low doses of ionizing
RT   radiation.";
RL   Mutat. Res. 683:91-97(2010).
//